Implications of diabetes in patients with acute coronary syndromes - The Global Registry of Acute Coronary Events

被引:226
作者
Franklin, K
Goldberg, RJ
Spencer, F
Klein, W
Budaj, A
Brieger, D
Marre, M
Steg, PG
Gowda, N
Gore, JM
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Karl Franzens Univ Graz, Div Cardiol, Dept Internal Med, A-8010 Graz, Austria
[3] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland
[4] Concord Hosp, Coronary Care Unit, Sydney, NSW, Australia
[5] Hop Xavier Bichat, Dept Diabetol, Paris, France
[6] Hop Xavier Bichat, Dept Cardiol, Paris, France
关键词
D O I
10.1001/archinte.164.13.1457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There are limited data describing the presenting characteristics, management, and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS). Objective: To examine differences in these factors, patients with ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction, and unstable angina were enrolled in a large multinational coronary disease registry. Methods: The Global Registry of Acute Coronary Events is a prospective observational study of patients hospitalized with an ACS at 94 hospitals in 14 countries. The study sample consisted of 5403 patients with ST-segment elevation acute myocardial infarction, 4725 with non-ST-segment elevation acute myocardial infarction, and 5988 with unstable angina. Results: Approximately 1 in 4 patients presented to participating hospitals with a history of diabetes. Patients with diabetes were older, more often women, with a greater prevalence of comorbidities, and they were less likely to be treated with effective cardiac therapies than nondiabetic patients. Patients with diabetes who developed an ACS were at increased risk for each hospital outcome examined including heart failure, renal failure, cardiogenic shock, and death. These differences remained after adjustment for potentially confounding prognostic factors. Conclusions: A considerable proportion of patients with an ACS has diabetes and is at increased risk for adverse outcomes compared with patients without diabetes. There are certain proven therapeutic strategies that remain underused in the diabetic population. A more widespread awareness of this increased risk and a more diligent use of proven cardiac treatment approaches are indicated for patients with diabetes who develop an ACS.
引用
收藏
页码:1457 / 1463
页数:7
相关论文
共 36 条
  • [21] The impact of diabetes mellitus on survival after myocardial infarction:: can it be modified by drug treatment?: Results of a population-based myocardial infarction register follow-up study
    Löwel, H
    Koenig, W
    Engel, S
    Hörmann, A
    Keil, U
    [J]. DIABETOLOGIA, 2000, 43 (02) : 218 - 226
  • [22] Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
    Mak, KH
    Moliterno, DJ
    Granger, CB
    Miller, DP
    White, HD
    Wilcox, RG
    Califf, RM
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) : 171 - 179
  • [23] Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
    Mak, KH
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 563 - 568
  • [24] Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction - Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry
    Malmberg, K
    Yusuf, S
    Gerstein, HC
    Brown, J
    Zhao, F
    Hunt, D
    Piegas, L
    Calvin, J
    Keltai, M
    Budaj, A
    [J]. CIRCULATION, 2000, 102 (09) : 1014 - 1019
  • [25] Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus - Results of the EPISTENT (Evaluation of Platelet IIb/IIIa inhibitor for Stenting Trial) diabetic substudy
    Marso, SP
    Lincoff, AM
    Ellis, SG
    Bhatt, DL
    Tanguay, JF
    Kleiman, NS
    Hammoud, T
    Booth, JE
    Sapp, SK
    Topol, EJ
    [J]. CIRCULATION, 1999, 100 (25) : 2477 - 2484
  • [26] Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes - Findings from the GUSTO-IIb Study
    McGuire, DK
    Emanuelsson, H
    Granger, CB
    Ohman, EM
    Moliterno, DJ
    White, HD
    Ardissino, D
    Box, JW
    Califf, RM
    Topol, EJ
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (21) : 1750 - 1758
  • [27] Impact of diabetes on mortality after the first myocardial infarction
    Miettinen, H
    Lehto, S
    Salomaa, V
    Mähönen, M
    Niemelä, M
    Haffner, SM
    Pyörälä, K
    Tuomilehto, J
    [J]. DIABETES CARE, 1998, 21 (01) : 69 - 75
  • [28] PREVALENCE AND MORTALITY OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITH DIABETES
    RYTTER, L
    TROELSEN, S
    BECKNIELSEN, H
    [J]. DIABETES CARE, 1985, 8 (03) : 230 - 234
  • [29] ACUTE MYOCARDIAL-INFARCTION IN DIABETES-MELLITUS AND SIGNIFICANCE OF CONGESTIVE HEART-FAILURE AS A PROGNOSTIC FACTOR
    SAVAGE, MP
    KROLEWSKI, AS
    KENIEN, GG
    LEBEIS, MP
    CHRISTLIEB, AR
    LEWIS, SM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (10) : 665 - 669
  • [30] SIMPFENDORFER C, 1993, CLEV CLIN J MED, V60, P145